Tate & Lyle Regulatory News (TATE)

19 Nov 2018 07:00

19 November 2018

Tate & Lyle PLC

Board changes

Tate & Lyle PLC (the “Company”) announces that Warren Tucker has been appointed as a non-executive director and a member of the Audit, Remuneration and Nominations Committees with immediate effect.

Warren is a non-executive director of Reckitt Benckiser Group plc and of Thomas Cook Group plc where he is also Chair of the Remuneration Committee. He is a non-executive director and Chair of the Audit Committee of Survitec Topco Ltd. Warren, a Chartered Accountant, served as CFO on the Board of Cobham Plc for 10 years until 2013, where he co-led the company’s organic and strategic growth. Previously, Warren held senior finance roles at Cable & Wireless and British Airways.

Dr Gerry Murphy, Chairman of Tate & Lyle, said “I am delighted that Warren has agreed to join the Board. His finance background and significant experience of strategy, acquisitions and expansion into developing markets, will be of significant benefit to the Board.”

There are no further disclosures to be made in connection with Mr Tucker’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2018, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com

Claire-Marie O’Grady

Company Secretary

Tate & Lyle PLC

View source version on businesswire.com: https://www.businesswire.com/news/home/20181118005024/en/

Copyright Business Wire 2018